Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Summary

The purpose of this study is to determine whether the study drug is effective and safe in the first line treatment of patients with small cell lung cancer

Timeline

Start

2006-04

Primary completion

2007-04

Completion

2007-04

Outcome

Outcome not reported

Stopped: “Since only 1 of the first 10 subjects responded to the study treatment, it was decided to stop the trial due to lack of efficacy .”

Drugs

Indications